GLP-1 Receptor Agonists are not Just for Weight Loss—Can They Help Prevent and Treat Lymphedema? [keto low calorie gummy bears]

GLP-1 Receptor Agonists are not Just for Weight Loss—Can They Help Prevent and Treat Lymphedema? [keto low calorie gummy bears]

| 1h 28m 28s | Video has closed captioning.

GLP-1 Receptor Agonists are not Just for Weight Loss—Can They Help Prevent and Treat Lymphedema? Dr. Joseph Dayan is a board-certified plastic and reconstructive surgeon with a focus on lymphedema surgery and breast reconstruction. Dr. Dayan obtained his medical degree from the University of Vermont College of Medicine, followed by a plastic surgery residency at Georgetown University Hospital. He completed a fellowship in advanced microsurgical reconstruction at Chang Gung Memorial Hospital in Taiwan. With a passion for medical innovation, Dr. Dayan also completed an executive MBA from the Massachusetts Institute of Technology. Dr. Dayan spent ten years at Memorial Sloan Kettering Cancer Center, where he established the lymphatic surgery program. In 2024, Dr. Dayan established The Institute for Lymphatic Surgery and Innovation within the Institute for Advanced Reconstruction. This LE&RN Center of Excellence focuses on integrating technological, pharmacological, and surgical innovations to improve outcomes for patients with lymphedema. Dr. Dayan has been performing lymphatic surgery for over fifteen years and is an internationally recognized leader in the field. He has pioneered surgical techniques with a focus on elevating the standard of care through innovation and research. Dr. Dayan is a recipient of the Godina Traveling Fellowship, recognizing his contributions to the field of lymphedema surgery. He has over 100 peer-reviewed publications and numerous book chapters, and he recently published the textbook “Multimodal Management of Upper and Lower Extremity Lymphedema.” Dr. Dayan was the founding president of the American Society for Lymphatic Surgery and a board member of the Lymphatic Education & Research Network to advocate for patients with lymphedema. Dr. Dayan has been recognized as Castle Connolly's America's Top Doctor in 2024, Top Doctor in the New York Metro Area in 2023, and national and regional Top Doctor in New York Magazine from 2016 to 2020. Subscribe to our channel to get more videos like this one: Do you Have a Question for One of Our Experts: Share this Video: JOIN THE FIGHT!: About Lymphatic Education & Research Network (LE&RN): LE&RN's mission is to fight lymphatic diseases through education, research, and advocacy. We seek to accelerate the prevention, treatments and cures for lymphedema, lipedema, lymphatic anomalies, and the continuum of lymphatic diseases. About LE&RN The Lymphatic Education & Research Network (LE&RN) is an internationally recognized non-profit organization founded in 1998 to fight lymphatic disease (LD) through education, research, and advocacy. Lymphatic diseases include lymphedema (LE), lipedema, and lymphatic anomalies. LE&RN is equally committed to investigating preventive and therapeutic benefits for a broad array of diseases that are impacted by lymphatic function, such as heart disease, obesity, AIDS, Rheumatoid arthritis, diabetes, and cancer metastasis. To accomplish these goals, LE&RN sponsors research fellowship grants, an international patient registry and biorepository, live-stream symposiums, the peer-reviewed journal Lymphatic Research & Biology, weekly e-newsletters, scholarship grants to lymphedema therapists, conference travel awards to young researchers, and a vibrant website with features such as Ask the Experts, connecting patients with the field’s more renowned practitioners. LE&RN has Chapters and Centers of Excellence globally. In 2016, LE&RN created World Lymphedema Day on March 6th, which was established by unanimous vote of the United States Senate. Facebook: